REGEN BIOPHARMA, INC. (RGBP) Total liabilities 2016–2025
REGEN BIOPHARMA, INC. (RGBP) total liabilities at each fiscal year-end, per SEC filings.
$6.6MFY2025 · since FY2016: $906,258 → $6.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $6.6M | +21.9% |
| FY2024 | $5.4M | -1.5% |
| FY2023 | $5.5M | -36.5% |
| FY2022 | $8.6M | -41.5% |
| FY2021 | $14.7M | +97.1% |
| FY2020 | $7.5M | -32.2% |
| FY2019 | $11.0M | +18.0% |
| FY2018 | $9.3M | +50.6% |
| FY2017 | $6.2M | +583.6% |
| FY2016 | $906,258 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice